Squamous Cell Carcinoma

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Perspectives on the Science: Ipi/Nivo for Advanced MCC

We provide a commentary on the recent Lancet Oncology article on Ipi/Nivo advanced MCC.

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Perspectives on the Science: Neoadjuvant Cemiplimab for High-Risk CSCC

We provide a commentary on the recent NEJM article on neoadjuvant cemiplimab for advanced CSCC.

Cutaneous Malignancies: How Would You Manage This Patient?

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement

Prognostic Gene Expression Profiling for Cutaneous Squamous Cell Carcinoma: Does it Add to Staging

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

Society guidelines for the management of NMSC.